Epigenetic control of somatostatin and cortistatin expression by β amyloid peptide

J Neurosci Res. 2012 Jan;90(1):13-20. doi: 10.1002/jnr.22731. Epub 2011 Sep 15.

Abstract

β Amyloid, present in senile plaques, has been related largely to neuronal loss in the brain of patients with Alzheimer's disease. However, how neurons respond to β amyloid insults is still poorly understood. Here we show that β amyloid increases somatostatin and cortistatin gene expression mainly through an increase in histone 3 lysine 4 methylation (H3K4me3), a modification associated with transcriptional activation. Somatostatin and cortistatin partially decreased β amyloid toxicity in primary cortical neurons in culture. Thus we suggest that neurons respond to β amyloid insults by releasing somatostatin and cortistatin, which will act as a protective agent against β amyloid toxicity. Our results suggest a relevant function for both neuropeptides against β amyloid toxicity, providing new insights into Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Drug Interactions
  • Embryo, Mammalian
  • Epigenomics*
  • Gene Expression Regulation / drug effects*
  • Glycogen Synthase Kinase 3 / metabolism
  • In Vitro Techniques
  • Mice
  • Mice, Inbred C57BL
  • Neurons / drug effects*
  • Neuropeptides / genetics
  • Neuropeptides / metabolism*
  • Phosphorylation / drug effects
  • Serine / metabolism
  • Somatostatin / genetics
  • Somatostatin / metabolism*
  • Somatostatin / pharmacology
  • Tubulin / metabolism

Substances

  • Amyloid beta-Peptides
  • Neuropeptides
  • Tubulin
  • cortistatin
  • Serine
  • Somatostatin
  • Glycogen Synthase Kinase 3